bpc-157 clinical trials humans safety efficacy If worked as well as the internet says it does… …we'd probably have high quality human by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of What is BPC-157? | Everything
Description
The mechanism appears unrelated to the lipolytic pathway
MATERIALS AND METHODS Rationale for Dose Selection Results of a previous study performed in sarcoidosis patients with painful small-fiber neuropathy showed that 2 mg ARA 290 administered intravenously (IV) three times weekly improved neuropathic symptoms
A rodent-based thyroid boxed warning carries no human signal at trial resolution, with a personal or family history of medullary thyroid cancer or MEN2 as a contraindication
So, Ill keep an eye on them and Im going to call my doctor on Monday
Consult with your healthcare provider to determine if this is a suitable option
366 , 367 , 368 It is unclear how these differential impacts on women may affect their brain health in the future
